135 related articles for article (PubMed ID: 33246926)
1. Risk for cardiovascular events following 'microsize' versus usual myocardial infarctions.
Almarzooq ZI; Colantonio LD; Okin PM; Richman JS; Brown TM; Levitan EB; Bryan J; Safford MM
Heart; 2021 Jul; 107(14):1152-1159. PubMed ID: 33246926
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for 'microsize' vs. usual myocardial infarctions in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Almarzooq ZI; Colantonio LD; Okin PM; Richman JS; Brown TM; Levitan EB; Bryan J; Safford MM
Eur Heart J Qual Care Clin Outcomes; 2019 Oct; 5(4):343-351. PubMed ID: 30843051
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.
Sterling MR; Durant RW; Bryan J; Levitan EB; Brown TM; Khodneva Y; Glasser SP; Richman JS; Howard G; Cushman M; Safford MM
BMC Cardiovasc Disord; 2018 Apr; 18(1):66. PubMed ID: 29661151
[TBL] [Abstract][Full Text] [Related]
4. Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study.
Safford MM; Parmar G; Barasch CS; Halanych JH; Glasser SP; Goff DC; Prineas RJ; Brown TM
BMC Health Serv Res; 2013 May; 13():162. PubMed ID: 23635044
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Disease Events and Mortality After Myocardial Infarction Among Black and White Adults: REGARDS Study.
Blackston JW; Safford MM; Mefford MT; Freeze E; Howard G; Howard VJ; Naftel DC; Brown TM; Levitan EB
Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e006683. PubMed ID: 33302710
[TBL] [Abstract][Full Text] [Related]
6. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
[TBL] [Abstract][Full Text] [Related]
7. Clinical Relevance of Cardiac Troponin Assessment in Patients Undergoing Carotid Endarterectomy.
Grobben RB; Vrijenhoek JE; Nathoe HM; Den Ruijter HM; van Waes JA; Peelen LM; van Klei WA; de Borst GJ
Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):473-80. PubMed ID: 26553374
[TBL] [Abstract][Full Text] [Related]
8. Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial.
Wiviott SD; Giugliano RP; Morrow DA; De Ferrari GM; Lewis BS; Huber K; Kuder JF; Murphy SA; Forni DM; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR; Sabatine MS
JAMA Cardiol; 2020 Jul; 5(7):787-793. PubMed ID: 32347885
[TBL] [Abstract][Full Text] [Related]
9. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER.
Sabatine MS; De Ferrari GM; Giugliano RP; Huber K; Lewis BS; Ferreira J; Kuder JF; Murphy SA; Wiviott SD; Kurtz CE; Honarpour N; Keech AC; Sever PS; Pedersen TR
Circulation; 2018 Aug; 138(8):756-766. PubMed ID: 29626068
[TBL] [Abstract][Full Text] [Related]
10. Prehypertension and incident acute coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
Glasser SP; Khodneva Y; Lackland DT; Prineas R; Safford MM
Am J Hypertens; 2014 Feb; 27(2):245-51. PubMed ID: 24190905
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial.
Guimarães PO; Leonardi S; Huang Z; Wallentin L; de Werf FV; Aylward PE; Held C; Harrington RA; Moliterno DJ; Armstrong PW; White HD; Alexander KP; Lopes RD; Mahaffey KW; Tricoci P
Am Heart J; 2018 Feb; 196():28-35. PubMed ID: 29421012
[TBL] [Abstract][Full Text] [Related]
12. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
Serban MC; Colantonio LD; Manthripragada AD; Monda KL; Bittner VA; Banach M; Chen L; Huang L; Dent R; Kent ST; Muntner P; Rosenson RS
J Am Coll Cardiol; 2017 Mar; 69(11):1386-1395. PubMed ID: 28302290
[TBL] [Abstract][Full Text] [Related]
13. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study.
McCarthy CP; Ibrahim NE; Lyass A; Li Y; Gaggin HK; Simon ML; Mukai R; Gandhi P; Kelly N; Motiwala SR; van Kimmenade RRJ; Massaro JM; D'Agostino RB; Januzzi JL
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29519811
[TBL] [Abstract][Full Text] [Related]
14. Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Kikkert WJ; Hoebers LP; Damman P; Lieve KV; Claessen BE; Vis MM; Baan J; Koch KT; de Winter RJ; Piek JJ; Tijssen JG; Henriques JP
Am J Cardiol; 2014 Jan; 113(2):229-35. PubMed ID: 24188893
[TBL] [Abstract][Full Text] [Related]
15. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54.
Bonaca MP; Wiviott SD; Morrow DA; Steg PG; Hamm C; Bhatt DL; Storey RF; Cohen M; Kuder J; Im K; Magnani G; Budaj A; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Diaz R; Van de Werf F; Corbalán R; Goudev A; Jensen EC; Johanson P; Braunwald E; Sabatine MS
J Am Heart Assoc; 2018 Nov; 7(22):e009260. PubMed ID: 30571502
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in relation to high-sensitivity cardiac troponin T levels in patients with myocardial infarction and non-obstructive coronary arteries.
Hjort M; Lindahl B; Baron T; Jernberg T; Tornvall P; Eggers KM
Am Heart J; 2018 Jun; 200():60-66. PubMed ID: 29898850
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Clinically Unrecognized Myocardial Fibrosis in Patients With Suspected Coronary Artery Disease.
Antiochos P; Ge Y; Steel K; Bingham S; Abdullah S; Mikolich JR; Arai AE; Bandettini WP; Patel AR; Farzaneh-Far A; Heitner JF; Shenoy C; Leung SW; Gonzalez JA; Shah DJ; Raman SV; Ferrari VA; Schulz-Menger J; Stuber M; Simonetti OP; Kwong RY;
J Am Coll Cardiol; 2020 Aug; 76(8):945-957. PubMed ID: 32819469
[TBL] [Abstract][Full Text] [Related]
18. Use of Medicare Claims Data for the Identification of Myocardial Infarction: The Reasons for Geographic And Racial Differences in Stroke Study.
Colantonio LD; Levitan EB; Yun H; Kilgore ML; Rhodes JD; Howard G; Safford MM; Muntner P
Med Care; 2018 Dec; 56(12):1051-1059. PubMed ID: 30363020
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of patients with perioperative myocardial infarction as diagnosed by troponin I after routine surgical coronary artery revascularization.
Riedel BJ; Grattan A; Martin CB; Gal J; Shaw AD; Royston D
J Cardiothorac Vasc Anesth; 2006 Dec; 20(6):781-7. PubMed ID: 17138080
[TBL] [Abstract][Full Text] [Related]
20. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
